Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response
Safae Hamkour, Eefje Hm van der Heijden, Ana P. Lopes, Sofie L.M. Blokland, Cornelis P.J. Bekker, Cornelia G. Van Helden-Meeuwsen, Marjan A. Versnel, Aike A. Kruize, Timothy Rdj Radstake, Helen L. Leavis, Maarten R. Hillen, Joel Ag van Roon*
Research output: Contribution to journal › Article › Academic › peer-review
2Citations
(Scopus)
25Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response'. Together they form a unique fingerprint.